D-Index & Metrics Best Publications

Stephen S. Whitehead

National Institute of Allergy and Infectious Diseases
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Immunology D-index 69 Citations 13,854 178 World Ranking 1667 National Ranking 827

Overview

What is he best known for?

The fields of study he is best known for:

Virus
Gene
Immune system

Stephen S. Whitehead focuses on Virology, Dengue virus, Virus, Dengue fever and Dengue vaccine. He studies Virology, namely Neutralizing antibody. The study incorporates disciplines such as Serotype, Microbiology, Flavivirus and Vaccination in addition to Dengue virus.

His Virus research is multidisciplinary, incorporating elements of Molecular biology, Recombinant virus and Gene. His primary area of study in Dengue fever is in the field of Antibody-dependent enhancement. As a part of the same scientific study, he usually deals with the Dengue vaccine, concentrating on Viremia and frequently concerns with Clinical endpoint and Rash.

His most cited work include:

Prospects for a dengue virus vaccine. (477 citations)
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity (455 citations)
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. (379 citations)

What are the main themes of his work throughout his whole career to date?

Stephen S. Whitehead mostly deals with Virology, Dengue virus, Virus, Dengue fever and Immunology. As a part of the same scientific study, Stephen S. Whitehead usually deals with the Virology, concentrating on Antibody and frequently concerns with Zika virus. His Dengue virus research is multidisciplinary, incorporating perspectives in Viremia, Serotype, Immunity, Attenuated vaccine and Epitope.

Stephen S. Whitehead interconnects Molecular biology and Recombinant DNA in the investigation of issues within Virus. Stephen S. Whitehead works mostly in the field of Dengue fever, limiting it down to concerns involving T cell and, occasionally, Antigen. Stephen S. Whitehead has included themes like Titer and Immunogenicity in his Neutralizing antibody study.

He most often published in these fields:

Virology (87.50%)
Dengue virus (64.84%)
Virus (47.66%)

What were the highlights of his more recent work (between 2017-2020)?

Virology (87.50%)
Dengue virus (64.84%)
Dengue fever (46.09%)

In recent papers he was focusing on the following fields of study:

Stephen S. Whitehead spends much of his time researching Virology, Dengue virus, Dengue fever, Flavivirus and Dengue vaccine. His work deals with themes such as Attenuated vaccine and Antibody, which intersect with Virology. Dengue virus is a subfield of Immunology that he explores.

His work carried out in the field of Dengue fever brings together such families of science as Immune system and B cell. His Dengue vaccine research includes themes of Internal medicine, Clinical trial, Disease and Seroconversion. The various areas that Stephen S. Whitehead examines in his Virus study include Exome sequencing and Chronic infection.

Between 2017 and 2020, his most popular works were:

Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3. (46 citations)
Fetal Demise and Failed Antibody Therapy During Zika Virus Infection of Pregnant Macaques (46 citations)
Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization. (22 citations)

In his most recent research, the most cited papers focused on:

Virus
Gene
Immune system

Stephen S. Whitehead mainly investigates Virology, Dengue virus, Virus, Zika virus and Immunity. Virology is closely attributed to Disease in his work. Specifically, his work in Dengue virus is concerned with the study of Dengue vaccine.

His Virus research integrates issues from Fetus and Antibody. His studies in Immunity integrate themes in fields like Platelet, Genetic variation, Genotype and Dengue fever. His study in Vaccination is interdisciplinary in nature, drawing from both Epitope, Attenuated vaccine, Serotype and Flavivirus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prospects for a dengue virus vaccine.

Stephen S. Whitehead;Joseph E. Blaney;Anna P. Durbin;Brian R. Murphy.
Nature Reviews Microbiology (2007)

772 Citations

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

Martina Beltramello;Katherine L. Williams;Cameron P. Simmons;Annalisa Macagno.
Cell Host & Microbe (2010)

622 Citations

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

Ruth A. Karron;Deborah A. Buonagurio;Alice F. Georgiu;Stephen S. Whitehead.
Proceedings of the National Academy of Sciences of the United States of America (1997)

599 Citations

Immune Response to Dengue Virus and Prospects for a Vaccine

Brian R Murphy;Stephen S Whitehead.
Annual Review of Immunology (2011)

518 Citations

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

Anna P. Durbin;Ruth A. Karron;Wellington Sun;David W. Vaughn.
American Journal of Tropical Medicine and Hygiene (2001)

413 Citations

Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.

Alexander Bukreyev;Stephen S. Whitehead;Brian R. Murphy;Peter L. Collins.
Journal of Virology (1997)

376 Citations

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson.
The Journal of Infectious Diseases (2000)

368 Citations

Recombinant Respiratory Syncytial Virus Bearing a Deletion of either the NS2 or SH Gene Is Attenuated in Chimpanzees

Stephen S. Whitehead;Alexander Bukreyev;Michael N. Teng;Cai Yen Firestone.
Journal of Virology (1999)

311 Citations

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.

Michael N. Teng;Stephen S. Whitehead;Peter L. Collins.
Virology (2001)

304 Citations

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees.

Michael N. Teng;Stephen S. Whitehead;Alison Bermingham;Marisa St. Claire.
Journal of Virology (2000)

283 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Stephen S. Whitehead